<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Questions from patients about <z:chebi fb="29" ids="35480">analgesic</z:chebi> pharmacotherapy and responses from authors are presented to help educate patients and make them more effective self-advocates </plain></SENT>
<SENT sid="1" pm="."><plain>The topic addressed in this issue is <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD), a <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory, vascular, and/or <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> affecting the entire body, and discussion of symptoms, course of disease, treatments, prognosis, and quality of life </plain></SENT>
</text></document>